You hit your number! You know, the one you wrote down months ago and half-assumed you’d never actually see. Now you are asking yourself “What do I do now?”
Everything built around a GLP-1 is set up for the way down. A titration schedule, dose increases all planned out, a weight chart you can watch drop week by week. Now you’ve reached your goal and all of that seems less important. The stretch that comes with the least support turns out to be the one that decides whether any of it was worth it.
This article is general information, not medical advice. It does not give dosing or treatment guidance, and nothing here is a reason to start, stop or change a medication on your own. Talk to your prescriber or dietitian about decisions specific to you.
Let’s start with the number that should worry you about all this. In the STEP-1 trial extension, researchers followed people after they stopped semaglutide, and the weight came back. On average about two-thirds of what had been lost returned within a year of the final injection, with the line still climbing when the data ran out. By roughly eighteen months most of the loss had reversed as willpower isn’t really the variable here. Take away the thing that was holding your appetite, and therefore weight, down and your body does what it was always going to do.
Maintenance is a different job
Most people picture maintenance as losing weight with the effort turned down a notch. Unfortunately, that picture sets them up to fail, because losing weight on one of these drugs comes with a lot of help that maintenance doesn’t. The medication does a chunk of the work and the scale rewards you most weeks. There’s a target up ahead pulling you forwards. Hit your goal and all three disappear at once: the number stops moving so the feedback goes flat, the appetite suppression is either tapering off or working so quietly that you’ve stopped noticing food at all, and the thing you were chasing is now behind you. “Keep doing what you were doing” sounds simple right up until you accept that what you were doing leaned on tailwinds that have gone.
While the weight was coming off, habits could slip and it barely showed, because the drug covered the gap. Once you stop and move into maintenance there’s nothing covering it.
The activity that leaks away while you’re winning
Watch what happens to movement on these drugs. At ENDO 2026, the Endocrine Society’s annual meeting in Chicago, Dr Sajana Maharjan presented tracker data from 753 adults with obesity, measured before and after they started a GLP-1. Daily steps fell from 5,047 to 4,487. Moderate-to-vigorous activity dropped from 28 minutes a day to 22. The weight came off while, almost counter-intuitively, people were moving less than they had been before.
Nobody decides to do this. You’re carrying less, you’re less hungry and the scale keeps confirming that everything’s on track and as such there’s less pushing you out the door. The one number most people bother to watch is heading the right way the whole time your activity is sliding under the radar. By the time maintenance starts, your daily movement may already sit well below where you began, and that lower baseline is the floor you’re now trying to hold a steady weight on top of.
Both of those, less muscle and fewer steps, make the weight easier to regain later, especially if you ever come off the drug. Neither one shows up on the scale, which is busy showing you a win.
What actually holds the line
None of this replaces your prescriber’s plan; it’s the practical scaffolding the research keeps circling back to, and most of why it gets skipped is that it’s just not that interesting!
Protein earns its place at the top. The figure clinicians keep arriving at is roughly 0.5 to 0.7 grams per pound of body weight a day (about 1.2 to 1.6 grams per kilogram) — which works out to about 96 to 128 grams for someone at 176 lb (80 kg), or 78 to 104 grams at 143 lb (65 kg). It’s the most filling thing on the plate, which is exactly why it’s first to slide once a drug has shrunk your appetite: you’re full before you’ve eaten enough of it. In maintenance, protein is what your muscle needs to stay put, and muscle is a big part of what keeps the weight off.
Movement has to be on purpose now, because you may well have just let it go as the weight dropped off. Two resistance sessions a week gets you most of the muscle-retention benefit the studies report, and there’s no need for a programme with a name or a rack of barbells. Steps are their own thing: the drift Maharjan’s team measured is reversible, but only by someone who is actually aware of it. A streak you keep half an eye on beats a good intention to “stay active” every single time.
Then the one almost everyone drops at exactly the wrong moment is the tracking. Hitting your goal feels like permission to stop logging, and that’s what shows you when things start to head in the wrong direction. The point of daily tracking in maintenance isn’t any single day’s number. What you’re buying is lead time: a slow creep upward turns up in a fortnight of data long before it turns up in how your jeans fit, and 7 pounds (3 kg) caught early is a smaller correction than 11 pounds (5 kg) or more.
Your clinician isn’t in the room for the other 360 days
You might see your prescriber three or four times a year. Maintenance happens in the 360-odd days in between: the ordinary week when the protein slipped, the fortnight when the weight crept up a notch and you decided it was probably water. That’s where regain is actually won or lost, and it’s the stretch with no clinician anywhere near the room.
That gap is the job we built Traqr for. It’s the thing you open on a normal Tuesday to review your dose, your weight, your protein and where all your information is sitting in one place. When you look at Traqr it is far easier to spot a trend rather than a surprise you explain to your doctor half a year later. We’ve also put a moderated peer community inside the same app, so the people who are a few months ahead of you in maintenance are right there next to you. It’s peer support, not medical advice; the clinical calls stay with your clinician. But on the flat, unrewarding days, it helps to know other people are grinding through the same stretch and have your back.
Crossing that line was real, and worth every week it took to get there. It also isn’t where the job ends. The part that decides whether the weight stays off is the part you’ll get the least help with. So the watching comes down to you: your protein and the slow trend on the scale will show you a drift weeks before it becomes something you have to explain to anyone. And don’t let your activity quietly slide while they do.
Sources
- STEP-1 trial extension — Wilding et al., Diabetes, Obesity and Metabolism, 2022: participants regained roughly two-thirds of lost weight within one year of stopping once-weekly semaglutide, with cardiometabolic gains also reversing.
- Endocrine Society / ENDO 2026 — “Exercise decreases among people taking GLP-1 medication” (Maharjan et al., presented June 2026; data via NIH All of Us): daily steps 5,047 → 4,487, moderate-to-vigorous activity 28 → 22 minutes/day after starting a GLP-1. See our 16 June piece, “Losing muscle, moving less.”
- Medscape — “The GLP-1 era demands a new model of obesity care” (2026): the case for restructuring obesity care around long-term maintenance rather than the active-loss phase.
- Protein and resistance-training targets for lean-mass preservation: ADA 2026 “quality of weight loss” sessions, ~1.2–1.6 g/kg/day plus resistance training. See our 19 June piece, “Are you really losing muscle on your GLP-1?”